Bradmer Pharmaceuticals Inc.
2 clinical trials · Sponsor
◉ Watch Bradmer Pharmaceuticals Inc.
| Record | Firm | Date |
|---|---|---|
| Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme (NCT00906516) | Bradmer Pharmaceuticals Inc. | 2009-05-01 |
| Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy (NCT00615186) | Bradmer Pharmaceuticals Inc. | 2008-06-01 |
Track Bradmer Pharmaceuticals Inc. automatically
Every clearance here is in the API, with alerts when new ones post.